Functions of the Complement Components C3 and C5 During Sepsis

Overview

Journal FASEB J

Specialties Biology
Physiology

Date 2008 Jul 1

PMID 18587006

Citations 45

Authors

Michael A Flierl

Daniel Rittirsch

Brian A Nadeau

Danielle E Day

Firas S Zetoune

J Vidya Sarma

Markus S Huber-Lang

Peter A Ward

Affiliations

Soon will be listed here.

Abstract

Activation of the complement system is a key event in the pathogenesis of sepsis. Nevertheless, the exact mechanisms remain inadequately understood. In the current study, we examined the role of complement C3 and C5 in sepsis in wild-type and C3- or C5-deficient mice induced by cecal ligation and puncture. When compared to wild-type mice, C5(-/-) showed identical survival, and C3(-/-) presented significantly reduced survival. Interestingly, this was associated with significant decreases in plasma levels of proinflammatory mediators. Moreover, although septic C3(-/-) animals displayed a 10-fold increase of blood-borne bacteria, C5(-/-) animals exhibited a 400-fold increase in bacteremia when compared to wild-type mice. These effects were linked to the inability of C5(-/-) mice to assemble the terminal membrane attack complex (MAC), as determined by complement hemolytic activity (CH-50). Surprisingly, although negative control C3(-/-) mice failed to generate the MAC, significant increases of MAC formation was found in septic C3(-/-) mice. In conclusion, our data corroborate that hemolytic complement activity is essential for control of bacteremia in septic mice. Thus, during sepsis, blockade of C5a or its receptors (rather than C5) seems a more promising strategy, because C5a-blockade still allows for MAC formation while the adverse effects of C5a are prevented.

Citing Articles

The complement system: A key player in the host response to infections.

Jayaraman A, Walachowski S, Bosmann M Eur J Immunol. 2024; 54(11):e2350814.

PMID: 39188171 PMC: 11623386. DOI: 10.1002/eji.202350814.

[Value of complement component 3 in predicting the prognosis of children with sepsis].

Peng Z, Yan H, Lu X, Zhang X, Huang J, Xiao Z Zhongguo Dang Dai Er Ke Za Zhi. 2023; 25(9):941-946.

PMID: 37718400 PMC: 10511224. DOI: 10.7499/j.issn.1008-8830.2304041.

Oral microbiome mediated inflammation, a potential inductor of vascular diseases: a comprehensive review.

Gualtero D, Lafaurie G, Buitrago D, Castillo Y, Vargas-Sanchez P, Castillo D Front Cardiovasc Med. 2023; 10:1250263.

PMID: 37711554 PMC: 10498784. DOI: 10.3389/fcvm.2023.1250263.

Characterization and functional analysis of hybrid pearl gentian grouper (♂ × ♀) complement C3 against infection.

Mo Z, Jiang B, Lai X, Wu H, Luo X, Dan X Fish Shellfish Immunol Rep. 2022; 2:100032.

PMID: 36420490 PMC: 9680070. DOI: 10.1016/j.fsirep.2021.100032.

C3-dependent effector functions of complement.

Zarantonello A, Revel M, Grunenwald A, Roumenina L Immunol Rev. 2022; 313(1):120-138.

PMID: 36271889 PMC: 10092904. DOI: 10.1111/imr.13147.

References

Osuchowski M, Welch K, Yang H, Siddiqui J, Remick D . Chronic sepsis mortality characterized by an individualized inflammatory response. J Immunol. 2007; 179(1):623-30. PMC: 4429887. DOI: 10.4049/jimmunol.179.1.623. View

Huber-Lang M, Younkin E, Sarma J, McGuire S, Lu K, Guo R . Complement-induced impairment of innate immunity during sepsis. J Immunol. 2002; 169(6):3223-31. DOI: 10.4049/jimmunol.169.6.3223. View

Gerard C . Complement C5a in the sepsis syndrome--too much of a good thing?. N Engl J Med. 2003; 348(2):167-9. DOI: 10.1056/NEJMcibr022995. View

Levy M, Fink M, Marshall J, Abraham E, Angus D, Cook D . 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med. 2003; 31(4):1250-6. DOI: 10.1097/01.CCM.0000050454.01978.3B. View

Bone R . Toward a theory regarding the pathogenesis of the systemic inflammatory response syndrome: what we do and do not know about cytokine regulation. Crit Care Med. 1996; 24(1):163-72. DOI: 10.1097/00003246-199601000-00026. View

Leinhase I, Rozanski M, Harhausen D, Thurman J, Schmidt O, Hossini A . Inhibition of the alternative complement activation pathway in traumatic brain injury by a monoclonal anti-factor B antibody: a randomized placebo-controlled study in mice. J Neuroinflammation. 2007; 4:13. PMC: 1867808. DOI: 10.1186/1742-2094-4-13. View

MULLER-EBERHARD H . Molecular organization and function of the complement system. Annu Rev Biochem. 1988; 57:321-47. DOI: 10.1146/annurev.bi.57.070188.001541. View

Prodeus A, Zhou X, Maurer M, Galli S, Carroll M . Impaired mast cell-dependent natural immunity in complement C3-deficient mice. Nature. 1997; 390(6656):172-5. DOI: 10.1038/36586. View

Kochanek K, Smith B . Deaths: preliminary data for 2002. Natl Vital Stat Rep. 2004; 52(13):1-47. View

10.

Brekke O, Christiansen D, Fure H, Fung M, Mollnes T . The role of complement C3 opsonization, C5a receptor, and CD14 in E. coli-induced up-regulation of granulocyte and monocyte CD11b/CD18 (CR3), phagocytosis, and oxidative burst in human whole blood. J Leukoc Biol. 2007; 81(6):1404-13. DOI: 10.1189/jlb.0806538. View

11.

Riedemann N, Guo R, Ward P . The enigma of sepsis. J Clin Invest. 2003; 112(4):460-7. PMC: 171398. DOI: 10.1172/JCI19523. View

12.

Ward P . The dark side of C5a in sepsis. Nat Rev Immunol. 2004; 4(2):133-42. DOI: 10.1038/nri1269. View

13.

Van Dijk H, Rademaker P, Willers J . Estimation of classical pathway of mouse complement activity by use of sensitized rabbit erythrocytes. J Immunol Methods. 1980; 39(3):257-68. DOI: 10.1016/0022-1759(80)90060-5. View

14.

Berg D, Kuhn R, Rajewsky K, Muller W, Menon S, Davidson N . Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance. J Clin Invest. 1995; 96(5):2339-47. PMC: 185885. DOI: 10.1172/JCI118290. View

15.

Fischer M, Prodeus A, Nicholson-Weller A, Ma M, Murrow J, Reid R . Increased susceptibility to endotoxin shock in complement C3- and C4-deficient mice is corrected by C1 inhibitor replacement. J Immunol. 1997; 159(2):976-82. View

16.

Mollnes T, Brekke O, Fung M, Fure H, Christiansen D, Bergseth G . Essential role of the C5a receptor in E coli-induced oxidative burst and phagocytosis revealed by a novel lepirudin-based human whole blood model of inflammation. Blood. 2002; 100(5):1869-77. View

17.

Dombrovskiy V, Martin A, Sunderram J, Paz H . Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003. Crit Care Med. 2007; 35(5):1244-50. DOI: 10.1097/01.CCM.0000261890.41311.E9. View

18.

Remick D . Cytokine therapeutics for the treatment of sepsis: why has nothing worked?. Curr Pharm Des. 2003; 9(1):75-82. DOI: 10.2174/1381612033392567. View

19.

Rittirsch D, Hoesel L, Ward P . The disconnect between animal models of sepsis and human sepsis. J Leukoc Biol. 2006; 81(1):137-43. DOI: 10.1189/jlb.0806542. View

20.

Newman S, Mikus L . Deposition of C3b and iC3b onto particulate activators of the human complement system. Quantitation with monoclonal antibodies to human C3. J Exp Med. 1985; 161(6):1414-31. PMC: 2187632. DOI: 10.1084/jem.161.6.1414. View